Free Trial

ReWalk Robotics Q2 2024 Earnings Report

ReWalk Robotics logo
$1.76 -0.08 (-4.08%)
As of 02/21/2025 04:00 PM Eastern

ReWalk Robotics EPS Results

Actual EPS
-$0.50
Consensus EPS
-$0.53
Beat/Miss
Beat by +$0.03
One Year Ago EPS
-$0.35

ReWalk Robotics Revenue Results

Actual Revenue
$6.71 million
Expected Revenue
$6.71 million
Beat/Miss
Met Expectations
YoY Revenue Growth
N/A

ReWalk Robotics Announcement Details

Quarter
Q2 2024
Time
Before Market Opens

ReWalk Robotics Earnings Headlines

Lifeward price target lowered to $4.50 from $6 at Lake Street
Lifeward sees FY24 revenue approximately $25.7M, consensus $25.32M
Trump doesn’t give a damn
Porter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met with one of Trump’s longest-serving advisors. We helped put together a plan to help investors capitalize on Trump’s election. And we found out these 10 stocks are the most likely to boom…
Lifeward CEO Larry Jasinski to step down
Lifeward Announces CEO Transition
ReWalk Robotics (NASDAQ:LFWD) Coverage Initiated at Laidlaw
See More ReWalk Robotics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ReWalk Robotics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ReWalk Robotics and other key companies, straight to your email.

About ReWalk Robotics

ReWalk Robotics (NASDAQ:LFWD), a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

View ReWalk Robotics Profile

More Earnings Resources from MarketBeat